Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Trading Statement

24 Nov 2016 07:00

RNS Number : 9924P
Exova Group PLC
24 November 2016
Β 

Β 

24 November 2016

Β 

Exova Group plc

Β 

Trading Update

Β 

On track to deliver 2016 earnings

Β 

Exova Group plc ("Exova"), a leading international provider of technically demanding testing, certification and advisory services, today releases a Trading Update for the period since 1 July 2016 to date. Where stated, the financial results are for the period from 1 January to 31 October 2016 compared with the corresponding period in 2015.

Β 

Group performance for the ten months to 31 October 2016

Β 

Β· Total revenue up 10.8% at actual rates; +3.7% at constant currency

o (0.2)% organic growth at constant currency (+5.7% excluding Oil, Gas & Industrials)

o 7.4% growth from acquisitions, 3.9% net of disposals

o Foreign exchange tailwind of 7.1% arising from our global footprint

Β· Despite a lower second half organic growth rate, continued good performance in Aerospace, Infrastructure & Environment, and Fire, Building Products & Certification (FBP&C)

Β· M&A pipeline continues to be strong and recent acquisitions performing well

Β 

Divisional performance in the period from 1 January 2016 to date

Β 

In Industries, we delivered strong organic growth performance in Aerospace. In addition, we have also seen continued progress with other industrial clients where we are now delivering positive growth. Oil & Gas remains challenging and we have no current visibility of any market improvement.

Β 

In Products, we saw continued strong organic growth in Fire, Building Products & Certification, however as expected, this was offset by lower levels of activity in Transportation as a result of reduced engine-testing as projects have completed.

Β 

In Infrastructure, Health & Environment, strong organic growth has continued across Infrastructure & Environment, principally driven by demand in the Middle East (albeit to more moderated levels than experienced in the first half). This has been complemented by solid organic growth within the Health Sciences sector.

Β 

Outlook

Β 

The Board expects full year earnings to be in line with previous guidance, despite more challenging conditions since the half-year. We now expect full year constant currency organic sales to be broadly flat.

Β 

For 2017, we continue to anticipate modest organic revenue growth supplemented by acquisitions, albeit with a less favourable business mix due to continuing pressures in Oil & Gas and the expected reduction in volumes in engine-testing.

Β 

Ian El-Mokadem, Chief Executive Officer, commented:

Β 

"The Group has made satisfactory progress in the first ten months of 2016. We continue to generate good organic growth outside of our Oil, Gas & Industrials sector, and our acquisitions programme continues to deliver. While we have taken some additional cost actions to mitigate the impact of the continued softness in Oil & Gas, we remain mindful of retaining our technical capabilities so that we are well positioned to benefit from a market recovery."

Β 

Contacts:

Β 

Peter Ogden / Andy Jones

Powerscourt Group

Tel. Direct +44 (0)20 7549 0997 / +44 (0)7793 858 211

exova@powerscourt-group.com

Β 

Phil Marshall, Chief Financial Officer

Exova Group plc

Tel. Direct +44 (0)7881 907 548

Investor.relations@exova.com

Β 

Β 

Exova

Β 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 138 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.

This Trading Update release contains forward-looking statements that involve substantial risks and uncertainties and actual results and developments may differ materially from those expressed or implied by these statements by a variety of factors. These forward-looking statements speak only as at the date of this press release. In addition, all projections, valuations and statistical analyses provided in this document may be based on unaudited pro-forma financial information, subjective assessments and assumptions. They may use alternative methodologies that produce different results and should not be relied upon as an accurate prediction of future performance.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTAKNDDOBDDBDB
Date   Source Headline
12th Jun 201710:17 amRNSForm 8.5 (EPT/RI)
12th Jun 201710:01 amRNSForm 8.3 - EXOVA GROUP PLC
12th Jun 20179:42 amRNSForm 8.5 (EPT/RI)
9th Jun 20174:41 pmRNSForm 8.5 (EPT/RI) - Replacement
9th Jun 20171:26 pmRNSResults of the Court Meeting and General Meeting
9th Jun 20171:08 pmRNSForm 8.3 - EXOVA GROUP PLC
9th Jun 201710:41 amRNSForm 8.5 (EPT/RI)
8th Jun 201710:07 amRNSForm 8.5 (EPT/RI)
8th Jun 20179:57 amRNSForm 8.3 - EXOVA GROUP PLC
7th Jun 20173:50 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jun 201711:56 amRNSForm 8.5 (EPT/RI)
7th Jun 201710:46 amRNSForm 8.3 - EXOVA GROUP PLC
7th Jun 201710:37 amRNSForm 8.5 (EPT/RI)
6th Jun 20173:30 pmRNSForm 8.3 - EXO LN
6th Jun 20173:25 pmBUSForm 8.3 - Exova Group PLC
6th Jun 20171:46 pmRNSForm 8.3 - Exova Group PLC
6th Jun 201710:56 amRNSForm 8.3 - EXOVA GROUP PLC
6th Jun 201710:47 amRNSForm 8.5 (EPT/RI)
6th Jun 201710:21 amRNSForm 8.3 - EXOVA GROUP PLC
5th Jun 201711:43 amRNSForm 8.5 (EPT/RI)
5th Jun 201710:57 amRNSForm 8.5 (EPT/RI)
5th Jun 20177:00 amRNSRecommended Acquisition of Exova Regulatory Update
2nd Jun 20171:22 pmRNSForm 8.3 - Exova Group PLC
2nd Jun 201711:06 amRNSForm 8.5 (EPT/RI)
2nd Jun 201711:04 amRNSForm 8.3 - EXOVA GROUP PLC
2nd Jun 201711:00 amRNSForm 8.5 (EPT/RI)
1st Jun 20171:31 pmRNSForm 8.3 - Exova Group Plc
1st Jun 201712:44 pmRNSTR-1: Notification of Major Interest in Shares
1st Jun 201710:47 amRNSForm 8.3 - Exova Group PLC
1st Jun 201710:47 amRNSForm 8.5 (EPT/RI)
31st May 201711:46 amRNSForm 8.3 - Exova Group Plc
31st May 201710:54 amRNSForm 8.5 (EPT/RI)
31st May 201710:48 amRNSForm 8.3 - EXOVA GROUP PLC
31st May 201710:44 amRNSForm 8.5 (EPT/RI)
30th May 20173:03 pmRNSForm 8.5 (EPT/RI) - Amendment
30th May 20172:00 pmBUSForm 8.3 - Exova Group Plc
30th May 20179:51 amRNSTR-1: Notification of Major Interest in Shares
30th May 20177:00 amRNSForm 8.3 - EXO LN
30th May 20177:00 amRNSForm 8.3 - EXOVA GROUP PLC
30th May 20177:00 amRNSForm 8.3 - EXOVA GROUP PLC
30th May 20177:00 amRNSForm 8.3 - EXOVA GROUP PLC
30th May 20177:00 amRNSForm 8.3 - Exova Group Plc
30th May 20177:00 amRNSForm 8.5 (EPT/RI)
26th May 20175:19 pmRNSRule 2.8 announcement
26th May 20174:24 pmRNSForm 8.5 (EPT/RI) - Amendment
26th May 201711:53 amRNSForm 8.5 (EPT/RI)
26th May 201710:27 amRNSForm 8.5 (EPT/RI)
26th May 201710:22 amRNSForm 8.3 - EXOVA GROUP PLC
25th May 201710:55 amRNSForm 8.5 (EPT/RI)
24th May 20173:18 pmRNSForm 8.3 - Exova Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.